 <h1>Nilandron Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>nilutamide</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about nilutamide. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Nilandron.</p><h2>In Summary</h2><p><b>Common side effects of Nilandron include:</b> nausea, night blindness, and decreased libido. <b>Other side effects include:</b> chest pain, fever, hemeralopia, visual disturbance, chromatopsia, and loss of body hair.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to nilutamide: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Interstitial pneumonitis has been reported in 2% of patients in controlled clinical trials of nilutamide. Reports of interstitial changes including pulmonary fibrosis that led to hospitalization and death have been reported rarely post-marketing. Symptoms included exertional dyspnea, cough, chest pain, and fever. A routine chest X-ray should be performed prior to initiating treatment and baseline pulmonary function tests may be considered. Patients should be instructed to report any new or worsening shortness of breath, and if symptoms occur, nilutamide should be discontinued until it can be determined if the symptoms are drug-related.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, nilutamide (the active ingredient contained in Nilandron) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking nilutamide:</p><p>
<i>More common</i>
</p><ul>
<li>Blood in the urine</li>
<li>blurred vision</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>diarrhea</li>
<li>difficult or labored breathing</li>
<li>dizziness</li>
<li>fever or chills</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>muscle aches and pains</li>
<li>nausea</li>
<li>nervousness</li>
<li>pale skin</li>
<li>pounding in the ears</li>
<li>runny nose</li>
<li>shivering</li>
<li>shortness of breath</li>
<li>slow or fast heartbeat</li>
<li>sneezing</li>
<li>sore throat</li>
<li>sweating</li>
<li>tightness in the chest</li>
<li>trouble with sleeping</li>
<li>troubled breathing with exertion</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>wheezing</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Arm, back, or jaw pain</li>
<li>blindness</li>
<li>bloody, black, or tarry stools</li>
<li>change in color vision</li>
<li>decreased urine output</li>
<li>decreased vision</li>
<li>difficulty seeing at night</li>
<li>dilated neck veins</li>
<li>fainting</li>
<li>fast or irregular heartbeat</li>
<li>increased cough</li>
<li>increased sensitivity of the eyes to sunlight</li>
<li>irregular breathing</li>
<li>swelling of the face, fingers, feet, or lower legs</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
<li>weight gain or loss</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of nilutamide may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>body hair loss</li>
<li>bone pain</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>changes in vision</li>
<li>decrease in testicle size</li>
<li>decreased interest in sexual intercourse</li>
<li>depression</li>
<li>difficulty having a bowel movement (stool)</li>
<li>dizziness</li>
<li>dry skin</li>
<li>feeling of warmth</li>
<li>heartburn</li>
<li>inability to have or keep an erection</li>
<li>increased urge to urinate during the night</li>
<li>indigestion</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>pain</li>
<li>rash</li>
<li>redness of the face, neck, arms and occasionally, upper chest</li>
<li>sleeplessness</li>
<li>stomach discomfort, upset, or pain</li>
<li>sudden sweating</li>
<li>unable to sleep</li>
<li>waking to urinate at night</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Difficulty with moving</li>
<li>dry mouth</li>
<li>general feeling of discomfort or illness</li>
<li>itching</li>
<li>muscle pain or stiffness</li>
<li>pain, swelling, or redness in the joints</li>
<li>passing of gas</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nilutamide: oral tablet</i></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (up to 10.5%)</p>
<p><b>Common</b> (1% to 10%): Interstitial pneumonitis, lung disorder, upper respiratory infection, pneumonia, increased cough, rhinitis</p>
<p><b>Postmarketing reports</b>: Interstitial or alveolo-interstitial changes (e.g.  pulmonary fibrosis)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Increased AST (up to 12.9%)</p>
<p><b>Common</b> (1% to 10%): Increased ALT, increased alkaline phosphatase, increased BUN, increased creatinine</p>
<p><b>Uncommon</b> (0.1% to 1%): Hepatitis</p>
<p><b>Rare</b> (less than 0.1%): Mixed hepatocellular-fulminant hepatitis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Impaired adaptation to dark (up to 57%)</p>
<p><b>Common</b> (1% to 10%): Chromatopsia, impaired adaptation to light, abnormal vision, cataract, photophobia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, angina, heart failure</p>
<p><b>Frequency not reported</b>: QT prolongation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, hematuria, melena, increased haptoglobin, leukopenia</p>
<p><b>Rare</b> (less than 0.1%): Aplastic anemia<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse events (especially nausea, alcohol intolerance, impairment of dark or light adaptation and dizziness) occur early during treatment and usually lessen after one month following dose reduction.<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Hot flushes (up to 66.5%), impotence (up to 11%), decreased libido (up to 11%), gynecomastia (up to 10.5%)</p>
<p><b>Common</b> (1% to 10%): Sweating, body hair loss<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Testicular atrophy (up to 16.3%)</p>
<p><b>Common</b> (1% to 10%): Urinary tract infection, urinary tract disorder, nocturia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pain (up to 26.8%), asthenia (up to 19.1%), peripheral edema (up to 12.4%), alcohol intolerance (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Chest pain, fever, flu syndrome, malaise, syncope<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 13.9%), dizziness (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Hypesthesia, paresthesia, nervousness<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Weight loss, hyperglycemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (up to 11.5%)</p>
<p><b>Common</b> (1% to 10%): Bone pain, arthritis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 16.3%)</p>
<p><b>Common</b> (1% to 10%): Depression<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 23.9%), constipation (up to 19.6%), abdominal pain (up to 10%)</p>
<p><b>Common</b> (1% to 10%): Dyspepsia, vomiting, diarrhea, gastrointestinal disorder, gastrointestinal hemorrhage, dry mouth<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Dry skin, rash, pruritus<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Nilandron (nilutamide)." Hoechst Marion-Roussel Inc, Kansas City, MO. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Nilandron (nilutamide)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Generic Availability</li>
<li>Drug class: antiandrogens</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nilandron &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Prostate Cancer</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nilutamide: oral tablet</i></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (up to 10.5%)</p><p><b>Common</b> (1% to 10%): Interstitial pneumonitis, lung disorder, upper respiratory infection, pneumonia, increased cough, rhinitis</p><p><b>Postmarketing reports</b>: Interstitial or alveolo-interstitial changes (e.g.  pulmonary fibrosis)<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Increased AST (up to 12.9%)</p><p><b>Common</b> (1% to 10%): Increased ALT, increased alkaline phosphatase, increased BUN, increased creatinine</p><p><b>Uncommon</b> (0.1% to 1%): Hepatitis</p><p><b>Rare</b> (less than 0.1%): Mixed hepatocellular-fulminant hepatitis<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Impaired adaptation to dark (up to 57%)</p><p><b>Common</b> (1% to 10%): Chromatopsia, impaired adaptation to light, abnormal vision, cataract, photophobia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, angina, heart failure</p><p><b>Frequency not reported</b>: QT prolongation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, hematuria, melena, increased haptoglobin, leukopenia</p><p><b>Rare</b> (less than 0.1%): Aplastic anemia<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse events (especially nausea, alcohol intolerance, impairment of dark or light adaptation and dizziness) occur early during treatment and usually lessen after one month following dose reduction.<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Hot flushes (up to 66.5%), impotence (up to 11%), decreased libido (up to 11%), gynecomastia (up to 10.5%)</p><p><b>Common</b> (1% to 10%): Sweating, body hair loss<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Testicular atrophy (up to 16.3%)</p><p><b>Common</b> (1% to 10%): Urinary tract infection, urinary tract disorder, nocturia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pain (up to 26.8%), asthenia (up to 19.1%), peripheral edema (up to 12.4%), alcohol intolerance (up to 10%)</p><p><b>Common</b> (1% to 10%): Chest pain, fever, flu syndrome, malaise, syncope<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 13.9%), dizziness (up to 10%)</p><p><b>Common</b> (1% to 10%): Hypesthesia, paresthesia, nervousness<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (up to 11%)</p><p><b>Common</b> (1% to 10%): Weight loss, hyperglycemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (up to 11.5%)</p><p><b>Common</b> (1% to 10%): Bone pain, arthritis<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Insomnia (up to 16.3%)</p><p><b>Common</b> (1% to 10%): Depression<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 23.9%), constipation (up to 19.6%), abdominal pain (up to 10%)</p><p><b>Common</b> (1% to 10%): Dyspepsia, vomiting, diarrhea, gastrointestinal disorder, gastrointestinal hemorrhage, dry mouth<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Dry skin, rash, pruritus<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Nilandron (nilutamide)." Hoechst Marion-Roussel Inc, Kansas City, MO. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Nilandron (nilutamide)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Generic Availability</li>
<li>Drug class: antiandrogens</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nilandron &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Prostate Cancer</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>